CSII - Cardiovascular Systems, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.78B
Enterprise Value 31.68B
Trailing P/E N/A
Forward P/E 1266.00
PEG Ratio (5 yr expected) 167.32
Price/Sales (ttm)7.19
Price/Book (mrq)11.93
Enterprise Value/Revenue 36.78
Enterprise Value/EBITDA 6641.43

Trading Information

Stock Price History

Beta (3Y Monthly) 1.29
52-Week Change 334.30%
S&P500 52-Week Change 32.99%
52 Week High 352.54
52 Week Low 324.84
50-Day Moving Average 348.43
200-Day Moving Average 342.26

Share Statistics

Avg Vol (3 month) 3304.86k
Avg Vol (10 day) 3246.04k
Shares Outstanding 535.27M
Float 33.79M
% Held by Insiders 13.61%
% Held by Institutions 186.94%
Shares Short (Aug 15, 2019) 41.57M
Short Ratio (Aug 15, 2019) 44.43
Short % of Float (Aug 15, 2019) 44.67%
Short % of Shares Outstanding (Aug 15, 2019) 44.52%
Shares Short (prior month Jul 15, 2019) 41.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Feb 26, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2019
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -0.10%
Operating Margin (ttm)-0.33%

Management Effectiveness

Return on Assets (ttm)-0.24%
Return on Equity (ttm)-0.18%

Income Statement

Revenue (ttm)248.02M
Revenue Per Share (ttm)7.40
Quarterly Revenue Growth (yoy)15.40%
Gross Profit (ttm)200.34M
EBITDA 2.62M
Net Income Avi to Common (ttm)-255k
Diluted EPS (ttm)-0.01
Quarterly Earnings Growth (yoy)-60.70%

Balance Sheet

Total Cash (mrq)122.67M
Total Cash Per Share (mrq)3.48
Total Debt (mrq)21.41M
Total Debt/Equity (mrq)14.47
Current Ratio (mrq)4.25
Book Value Per Share (mrq)4.24

Cash Flow Statement

Operating Cash Flow (ttm)10.21M
Levered Free Cash Flow (ttm)7.49M